Are Urinary Biomarkers Better Than Acute Kidney Injury Duration for Predicting Readmission?

Jeremiah R. Brown, Heather Thiessen-Philbrook, Christine A. Goodrich, Andrew R. Bohm, Shama S. Alam, Steven G. Coca, Eric McArthur, Amit X. Garg, Chirag R. Parikh

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Background: Acute kidney injury (AKI)is a common complication of cardiac surgery. Postprocedural AKI is a risk factor for 30-day readmission. We sought to examine the association of AKI and kidney injury biomarkers with readmission after cardiac surgery. Methods: Patients alive at discharge who underwent cardiac surgery from the Translational Research Investigating Biomarker Endpoints-AKI cohort were enrolled from six medical centers in the United States and Canada. AKI duration was defined as the total number of days AKI was present during index admission (no AKI, 1–2, 3–6, and 7+ days). Preoperative and postoperative urinary levels were collected for interleukin-18, neutrophil gelatinase–associated lipocalin, kidney injury molecule-1, liver-fatty-acid-binding protein, cystatin C, microalbumin, creatinine, and albumin-to-creatinine ratio. Readmission and death events were identified through US (Medicare)and Canadian administrative databases at 30 days and 365 days after discharge. Results: Of 968 patients 15.9% were readmitted or died within 30 days of discharge and 35.9% were readmitted or died within 365 days. AKI duration of 3 to 6 days was significantly associated with 30-day readmission or death (adjusted odds ratio, 1.82%; 95% confidence interval, 1.08–3.05). Patients with AKI duration ≥ 7 days had increased odds of readmission or death at both 30 days (adjusted odds ratio, 2.49%; 95% confidence interval, 1.15–5.43)and 365 days (adjusted odds ratio, 3.67%; 95% confidence interval, 1.73–7.79). Urinary biomarkers had no association with readmission and death. Conclusions: AKI duration ≥ 3 days, and not kidney biomarkers, was strongly associated with readmission or death. These clinical outcomes are potentially due to cardiovascular or hemodynamic causes rather than intrinsic injury to the kidney parenchyma.

Original languageEnglish (US)
Pages (from-to)1699-1705
Number of pages7
JournalAnnals of Thoracic Surgery
Issue number6
StatePublished - Jun 2019

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Are Urinary Biomarkers Better Than Acute Kidney Injury Duration for Predicting Readmission?'. Together they form a unique fingerprint.

Cite this